Lisa Caperelli | VP, IR |
William Collier | President, CEO & Director |
Michael Sofia | Chief Scientific Officer |
David Hastings | CFO & CAO |
Gaston Picchio | Chief Development Officer |
Douglas Buchanan | JMP Securities |
Yuchen Ding | Jefferies |
Thomas Yip | H.C. Wainwright & Co. |
Luke Herrmann | Robert W. Baird & Co. |
Keay Nakae | Chardan Capital Markets |
Good day, and thank you for standing by. Welcome to the Arbutus Biopharma 2022 First Quarter Financial Results and Corporate Update Conference Call. [Operator Instructions]. I would now like to hand the conference over to your first speaker today, Lisa Caperelli, Vice President of Investor Relations. Thank you, and please go ahead.